🇺🇸 FDA

Company profile · Sponsor

Alkermes

Alkermes Pharma Ireland

E3D24C6 · EMA pharma IE
Pipeline
4
Drugs
0
Patents
0

Quick answer

Alkermes (E3D24C6) is a pharma company. headquartered in IE. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E3D24C6
Exchange EMA
Company type pharma
Headquarters IE

Pipeline (4)

Search pipeline →

  1. ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680

    Alkermes

    Narcolepsy Type 1, Type 2 and Idiopathic Hypersomnia

    phase 3 small molecule active

    1 trial

  2. ALKS 2680, ALKS 2680, Placebo to match ALKS 2680, ALKS 2680

    Alkermes

    Idiopathic Hypersomnia (IH)

    phase 2 small molecule active

    1 trial

  3. Placebo to match ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680

    Alkermes

    Narcolepsy Type 1

    phase 2 small molecule active

    1 trial

  4. Placebo to match ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680

    Alkermes

    Narcolepsy Type 2

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Alkermes?

Alkermes (E3D24C6) is a pharma company. headquartered in IE. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Alkermes sponsor?

We track 4 ClinicalTrials.gov-linked programs for Alkermes, including ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Alkermes company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.